119 related articles for article (PubMed ID: 24880710)
1. Assessment of regression in successive primary melanomas.
Martín JM; Pinazo I; Mateo JF; Escandell I; Jordá E; Monteagudo C
Actas Dermosifiliogr; 2014 Oct; 105(8):768-73. PubMed ID: 24880710
[TBL] [Abstract][Full Text] [Related]
2. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens.
Saleh FH; Crotty KA; Hersey P; Menzies SW; Rahman W
J Pathol; 2003 Jul; 200(3):383-95. PubMed ID: 12845635
[TBL] [Abstract][Full Text] [Related]
3. Correlation of histologic regression in primary melanoma with sentinel node status.
Botella-Estrada R; Traves V; Requena C; Guillen-Barona C; Nagore E
JAMA Dermatol; 2014 Aug; 150(8):828-35. PubMed ID: 24898614
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous regression of multiple melanocytic nevi after melanoma: report of 3 cases.
Martín JM; Pinazo I; Monteagudo C; Markovic J; Allende A; Jordá E
Am J Dermatopathol; 2014 Nov; 36(11):e183-8. PubMed ID: 25343215
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous regression of metastatic melanoma - clinical evidence of the abscopal effect.
Bramhall RJ; Mahady K; Peach AH
Eur J Surg Oncol; 2014 Jan; 40(1):34-41. PubMed ID: 24139999
[TBL] [Abstract][Full Text] [Related]
6. The correlation of regression in primary melanoma with sentinel lymph node status.
Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
[TBL] [Abstract][Full Text] [Related]
7. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
Einwachter-Thompson J; MacKie RM
Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
[TBL] [Abstract][Full Text] [Related]
8. [Spontaneous regression and leukoderma in malignant melanoma].
Happle R; Schotola I; Macher E
Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
[TBL] [Abstract][Full Text] [Related]
9. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
10. A lack of significantly increased incidence of regression in second primary melanomas does not support an 'immunization effect'.
Zoller L; Mayer E; Itzhak OB; Bergman R
J Cutan Pathol; 2010 Nov; 37(11):1140-4. PubMed ID: 20726932
[TBL] [Abstract][Full Text] [Related]
11. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
12. [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].
Paredes BE
Pathologe; 2007 Nov; 28(6):453-63. PubMed ID: 17874109
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
Morris KT; Busam KJ; Bero S; Patel A; Brady MS
Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous regression of metastases from melanoma: review of the literature.
Kalialis LV; Drzewiecki KT; Klyver H
Melanoma Res; 2009 Oct; 19(5):275-82. PubMed ID: 19633580
[TBL] [Abstract][Full Text] [Related]
15. Study of the immunophenotype of the inflammatory cells in melanomas with regression and halo nevi.
Botella-Estrada R; Kutzner H
Am J Dermatopathol; 2015 May; 37(5):376-80. PubMed ID: 25222195
[TBL] [Abstract][Full Text] [Related]
16. [Studies of tumor exchange transplantations in inoperable melanomas].
Gartmann H; Tritsch H
Hautarzt; 1966 Dec; 17(12):529-33. PubMed ID: 5994834
[No Abstract] [Full Text] [Related]
17. Local immune response predicts survival in patients with thick (t4) melanomas.
Cintolo JA; Gimotty P; Blair A; Guerry D; Elder DE; Hammond R; Elenitsas R; Xu X; Fraker D; Schuchter LM; Czerniecki BJ; Karakousis G
Ann Surg Oncol; 2013 Oct; 20(11):3610-7. PubMed ID: 23838911
[TBL] [Abstract][Full Text] [Related]
18. Retrospective review of primary melanomas excised at Waikato Hospital, New Zealand, 2002-2003.
Barker S; Oakley A; Rademaker M
Australas J Dermatol; 2007 Feb; 48(1):14-7. PubMed ID: 17222295
[TBL] [Abstract][Full Text] [Related]
19. Association between natural killer cells and regression in melanocytic lesions.
McKay K; Moore PC; Smoller BR; Hiatt KM
Hum Pathol; 2011 Dec; 42(12):1960-4. PubMed ID: 21676435
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
